What Zepbound actually costs, in plain language

What this guide covers

What Zepbound (tirzepatide) costs with and without insurance, the manufacturer's self-pay vials, why the same drug has several prices, and how to find your real number. A calm map of the money side, with no stake in any of it. This is patient education, not a substitute for the prescriber who knows your case. Generic names sit next to brand names throughout: semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound).

Key points

• The honest disclaimer first. Drug prices in the United States move constantly, programs open and close, and what you pay for Zepbound depends on your insurance, your indication, and the channel you buy through. Everything below is accurate as of June 2026 and framed in ranges for exactly that reason. Treat this page as a map of the system, then verify the current number for your situation with your pharmacy, your plan, and the manufacturer's own pricing pages. Peptips takes no money from drug makers, pharmacies, or telehealth sellers, so nothing here is steering you toward a buying path. If you are still deciding what Zepbound even is, our what is Zepbound guide covers the basics first.
• The list price, and why almost nobody pays it. Zepbound is tirzepatide (the same molecule as Mounjaro), and its U.S. list price for the auto-injector pens has sat above one thousand dollars for a month's supply, broadly in line with the rest of the branded GLP-1 class. The list price is the sticker on the system, the starting point for negotiations between Eli Lilly, insurers, and pharmacy middlemen. Most people pay something very different: a copay if insurance covers it, a manufacturer self-pay price if it does not, or a program price if they qualify. The useful question is never what does it list for, it is what would I pay through each door I can actually walk through.
• Door one: insurance, and why weight coverage is the hard part. Coverage follows the indication, and this is where Zepbound differs from a diabetes drug. Zepbound carries the chronic weight management approval (plus an obstructive sleep apnea approval based on the SURMOUNT-OSA trial), and many employer plans and state programs still exclude or restrict anti-obesity medication as a category, though that has been shifting year by year. When a plan does cover it, you pay your plan's copay, and commercially insured patients have at times been able to use a manufacturer savings card on top. The sleep apnea indication can sometimes change the coverage picture, which is worth raising with your prescriber. The only reliable way to know is to ask your plan about Zepbound for your specific diagnosis.
• Door two: manufacturer self-pay vials. Eli Lilly sells Zepbound directly to self-pay patients through its LillyDirect channel, including single-dose vials offered at flat monthly self-pay prices that launched well below the pen list price. In late 2025 the manufacturers also reached federal pricing agreements expected to push some direct-purchase prices further down during 2026. The honest summary: if your insurance says no, the manufacturer self-pay vial price is the number to check first, and it has generally been moving in the patient's favor. Because Zepbound and Mounjaro are the same drug, the cost conversation rhymes with the Mounjaro cost picture, just under a different label and indication.
• The door we would skip: compounded tirzepatide. During the shortage years, compounded tirzepatide from pharmacies and telehealth sellers was often the cheapest door. The FDA's position is worth knowing: compounded versions are not FDA-approved, the agency has warned about dosing errors and unverified ingredients, and once the shortage was declared resolved, the legal basis for mass-compounding copies largely ended. With manufacturer self-pay vials now priced far below the old pen list price, the gap that made compounding tempting has narrowed. We do not link to or take money from any seller in this space, and our honest read is that the approved product through a legitimate channel is the option your prescriber can actually stand behind.

Frequently asked questions